Korn, Edward L.
491  results:
Search for persons X
?
 
?
4

Augmenting randomized clinical trial data with historical c..:

Freidlin, Boris ; Korn, Edward L
JNCI: Journal of the National Cancer Institute.  115 (2022)  1 - p. 14-20 , 2022
 
?
5

Dose optimization during drug development: whether and when..:

Korn, Edward L ; Moscow, Jeffrey A ; Freidlin, Boris
JNCI: Journal of the National Cancer Institute.  115 (2022)  5 - p. 492-497 , 2022
 
?
6

Clinical Benefit Scales and Trial Design: Some Statistical ..:

Korn, Edward L ; Allegra, Carmen J ; Freidlin, Boris
JNCI: Journal of the National Cancer Institute.  114 (2022)  9 - p. 1222-1227 , 2022
 
?
9

Reply to Quartagno et al:

Freidlin, Boris ; Hu, Chen ; Korn, Edward L
Clinical Trials.  18 (2021)  6 - p. 746-746 , 2021
 
?
10

A Problematic Biomarker Trial Design:

Freidlin, Boris ; Korn, Edward L
JNCI: Journal of the National Cancer Institute.  114 (2021)  2 - p. 187-190 , 2021
 
?
12

Contributors:

, In: Abeloff's Clinical Oncology,
 
?
14

Muscle myosins form folded monomers, dimers, and tetramers ..:

Liu, Xiong ; Shu, Shi ; Korn, Edward D.
Proceedings of the National Academy of Sciences of the United States of America.  117 (2020)  27 - p. 15666-15672 , 2020
 
?
15

Muscle myosins form folded monomers, dimers, and tetramers ..:

Liu, Xiong ; Shu, Shi ; Korn, Edward D.
Proceedings of the National Academy of Sciences.  117 (2020)  27 - p. 15666-15672 , 2020
 
1-15